#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5148229	B	Activation of human recombinant AMPK A2/B2/G1 assessed as increase in AMPK phosphorylation using FL-peptide as substrate incubated for 120 mins by EZ reader method	Homo sapiens	15		protein complex format	Scientific Literature
2.	ALA5148230	A	Protein binding in serum (unknown origin) assessed as unbound fraction by equilibrium dialysis assay	Not specified	6		cell-free format	Scientific Literature
3.	ALA5148236	A	Metabolic stability in human liver microsomes assessed as compound remaining measured after 30 mins	Homo sapiens	4		microsome format	Scientific Literature
4.	ALA5148237	A	Metabolic stability in rat liver microsomes assessed as compound remaining measured after 30 mins	Rattus norvegicus	4		microsome format	Scientific Literature
5.	ALA5148238	A	AUC in rat at 1 mg/kg, po	Rattus norvegicus	4		organism-based format	Scientific Literature
6.	ALA5148239	A	Cmax in rat at 1 mg/kg, po or 0.5 mg/kg, iv	Rattus norvegicus	4		organism-based format	Scientific Literature
7.	ALA5148240	A	Permeability coefficient of the compound in rat liver at 1 mg/kg, po or 0.5 mg/kg, iv	Rattus norvegicus	4		organism-based format	Scientific Literature
8.	ALA5148241	A	Permeability coefficient of the compound in rat muscle at 1 mg/kg, po or 0.5 mg/kg, iv	Rattus norvegicus	4		organism-based format	Scientific Literature
9.	ALA5148242	A	Total clearance in rat at 1 mg/kg, po or 0.5 mg/kg, iv	Rattus norvegicus	4		organism-based format	Scientific Literature
10.	ALA5148243	F	Invivo activation of AMPK in mouse skeletal muscle assessed as increase in ACC phosphorylation level at 0.08 to 6.75 mg/kg,po by ELISA	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA5148244	F	Invivo activation of AMPK in mouse liver assessed as increase in AMPKalpha phosphorylation level at 0.08 to 6.75 mg/kg,po by western blot method	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA5148245	F	Antidiabetic activity against po dosed type 2 diabetic KKAy mouse model assessed as acute glucose lowering effect measured for 1 to 6 hrs	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA5148246	F	Antidiabetic activity against type 2 diabetic KKAy mouse model assessed as increase in Akt phosphorylation in skeletal muscle at 1.5 to 6 mg/kg,po bid measured on 25 to 26 days after insulin injection by ELISA	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA5148247	F	Antidiabetic activity against type 2 diabetic KKAy mouse model assessed as decrease in lipid accumulation in liver at 1.5 to 6 mg/kg,po bid measured on 25 to 26 days after insulin injection	Mus musculus	1		organism-based format	Scientific Literature
15.	ALA5148248	F	Antidiabetic activity against type 2 diabetic KKAy mouse model assessed as decrease in plasma glucose level administrated orally bid measured after 21 days of administration by automatic analyzer	Mus musculus	1		organism-based format	Scientific Literature
16.	ALA5148249	F	Antidiabetic activity against type 2 diabetic KKAy mouse model assessed as decrease in HbA1c level administrated orally bid measured after 21 days of administration by automatic analyzer	Mus musculus	1		organism-based format	Scientific Literature